Sign Up Today and Learn More About Seaport Therapeutics Stock
Invest in or calculate the value of your shares in Seaport Therapeutics or other pre-IPO companies through EquityZen's platform.
Seaport Therapeutics Stock (SEPT)
Seaport Therapeutics operates as a clinical stage biopharmaceutical company.
About Seaport Therapeutics Stock
Founded
2024
Headquarters
Boston, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Seaport Therapeutics Press Mentions
Stay in the know about the latest news on Seaport Therapeutics
Seaport Therapeutics to Participate in Two Upcoming Investor Conferences
businesswire • Mar 03, 2025
Seaport Therapeutics Presents New Meta-Analysis Examining Correlations Between Clinical Trial Design Factors and Placebo Response in Major Depressive Disorder Studies
biospace • Feb 24, 2025
Seaport Therapeutics Presents New Meta-Analysis Examining Correlations Between Clinical Trial Design Factors and Placebo Response in Major Depressive Disorder Studies
businesswire • Feb 21, 2025
Seaport Therapeutics Announces the Publication of New Research Demonstrating Increased Lymphatic Transport with up to 55 Percent Drug Absorption via Lymphatics with Glyph™ Platform
biospace • Feb 12, 2025
Seaport Therapeutics Announces the Publication of New Research Demonstrating Increased Lymphatic Transport with up to 55 Percent Drug Absorption via Lymphatics with Glyph™ Platform
morningstar • Feb 12, 2025
Seaport Therapeutics Management
Leadership team at Seaport Therapeutics
Chief Medical Officer and President of Clinical Development
Antony Loebel
Board of Director
James Healy
Join now and verify your accreditation status to gain access to:
- Seaport Therapeutics Current Valuation
- Seaport Therapeutics Stock Price
- Seaport Therapeutics Management
- Available deals in Seaport Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Seaport Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Seaport Therapeutics Revenue and Financials
- Seaport Therapeutics Highlights
- Seaport Therapeutics Business Model
- Seaport Therapeutics Risk Factors
- Seaport Therapeutics Research Report from SACRA Research
Trading Seaport Therapeutics Stock
How to invest in Seaport Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Seaport Therapeutics through EquityZen funds. These investments are made available by existing Seaport Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Seaport Therapeutics stock?
Shareholders can sell their Seaport Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
